Aatmaj Healthcare Ltd

Aatmaj Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aatmaj Healthcare Ltd

₹ 18.8 -0.79%
12 Jun - close price
Company website NSE - SME: AATMAJ
About

Incorporated in 2022, Aatmaj Healthcare Ltd provides multi-speciality and super-specially healthcare services[1]

Key Points

Business Overview:[1][2]
AHL is an NABH accredited healthcare provider of modern medical and surgical care solutions. Company has 6 Hospitals, 30 Consultant Doctors, and 330 beds extendable up to 430 beds. It has 15+ Facilities and Services, and 25+ Infrastructure And Equipment.

Website NSE - SM
  • Market Cap ₹ 42.4 Cr.
  • Current Price ₹ 18.8
  • High / Low ₹ 33.5 / 14.5
  • Stock P/E 66.2
  • Book Value ₹ 22.2
  • Dividend Yield 0.27 %
  • ROCE 3.39 %
  • ROE 1.29 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Stock is trading at 0.85 times its book value

Cons

  • Company has a low return on equity of 8.00% over last 3 years.
  • Earnings include an other income of Rs.1.32 Cr.
  • Company has high debtors of 459 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
13.42 13.74 8.57 7.17 8.51 11.03
8.84 8.49 4.70 8.49 8.10 9.89
Operating Profit 4.58 5.25 3.87 -1.32 0.41 1.14
OPM % 34.13% 38.21% 45.16% -18.41% 4.82% 10.34%
0.03 0.00 0.24 0.61 0.76 0.56
Interest 0.25 0.65 0.59 0.66 0.37 0.51
Depreciation 0.34 0.34 0.38 0.43 0.47 0.45
Profit before tax 4.02 4.26 3.14 -1.80 0.33 0.74
Tax % 27.61% 29.34% 27.39% -22.22% 6.06% 55.41%
2.90 3.01 2.29 -1.41 0.31 0.33
EPS in Rs 5.37 1.86 1.01 -0.62 0.14 0.15
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
4.13 15.49 20.26 23.74 14.84 19.53
3.46 10.20 12.75 13.91 12.29 17.98
Operating Profit 0.67 5.29 7.51 9.83 2.55 1.55
OPM % 16.22% 34.15% 37.07% 41.41% 17.18% 7.94%
0.01 0.00 0.00 0.03 0.85 1.32
Interest 0.50 0.44 0.24 0.90 1.25 0.88
Depreciation 0.36 0.39 0.43 0.69 0.81 0.92
Profit before tax -0.18 4.46 6.84 8.27 1.34 1.07
Tax % 50.00% 7.40% 26.02% 28.66% 34.33% 40.19%
-0.27 4.12 5.05 5.91 0.88 0.64
EPS in Rs -2.00 30.52 37.41 3.65 0.39 0.28
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 12.84% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 36%
3 Years: -1%
TTM: 32%
Compounded Profit Growth
10 Years: %
5 Years: 34%
3 Years: -50%
TTM: -27%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -31%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 8%
Last Year: 1%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 1.35 1.35 1.35 8.10 11.30 11.30
Reserves -2.28 1.84 6.92 6.08 38.18 38.82
8.76 4.33 5.18 11.69 5.47 10.06
1.50 2.28 4.03 5.14 2.73 3.07
Total Liabilities 9.33 9.80 17.48 31.01 57.68 63.25
8.02 8.21 10.87 11.17 18.18 18.00
CWIP 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00
1.31 1.59 6.61 19.84 39.50 45.25
Total Assets 9.33 9.80 17.48 31.01 57.68 63.25

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.54 6.11 9.55 5.33 -8.01 3.34
-0.18 -0.71 -3.37 -1.42 -7.82 -0.69
0.67 -4.87 -6.55 -3.78 26.32 -1.29
Net Cash Flow -0.05 0.53 -0.37 0.14 10.49 1.35

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 86.61 13.43 91.88 274.13 507.16 459.38
Inventory Days 64.68 18.38 104.50
Days Payable 494.37 148.80 214.88
Cash Conversion Cycle -343.07 -116.99 91.88 274.13 507.16 349.00
Working Capital Days 14.14 -21.44 52.07 231.55 658.92 577.68
ROCE % 63.84% 67.53% 46.64% 6.41% 3.39%

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Mar 2024Sep 2024Mar 2025
63.72% 63.72% 63.72% 63.72% 63.74%
36.27% 36.28% 36.28% 36.28% 36.26%
No. of Shareholders 2,5111,7721,5371,5221,409

Documents

Announcements

Annual reports

Concalls